Home · Stock · IAM

IAM Iambic Therapeutics Inc

Which ETFs hold IAM? Iambic Therapeutics Inc is held by 1 fund tracked by ETFpeek.

Held by 1 fund todayData as of 30 Oct 2026
HealthcareBiotechnology
$13.43
-43.6% 1y
$12.3952-week range$25.00
Market cap
$637M
CEO
Dr. Thomas Miller Ph.D.
Revenue growth (YoY)
+224.7%

Iambic Therapeutics, Inc. operates as a biotechnology company that develops therapeutics from its AI discovery platform that optimizes target product profiles and drug candidates in the United States and Internationally. It offers products, such as IAM-1363, a selective HER2 inhibitor; IAM-K1, a KIF18A inhibitor; IAM217 (a KIF18A inhibitor) and IAM-C1, a CDK2/4 inhibitor; and services, including drug discovery platform and molecular superintelligence platform which includes technologies, such as Enchant and NeuralPLexer to design and develop small molecule therapeutics. Iambic Therapeutics, Inc. was formerly known as Entos, Inc. and changed its name to Iambic Therapeutics, Inc. in May 2023. The company was incorporated in 2019 and is based in San Diego, California.

Provider

Currently Held By

ARK
ARKG
ARK Genomic Revolution ETF
Weight in fund0.81%
Shares held1,367,917
Market value$19.5M
View fund →
Not held by the selected provider.
last 90 days
No notable insider activity in the last 90 days. Show all 16 trades
Net flow (90d):value not reported·16 BUY / 0 SELL·showing all trades
DatePersonActionPlanSharesValueScore i
14 Oct 2026
Frederick R Manby
Director / Other
BUYVested (RSU)925,400
2 tranches
—30
14 Oct 2026
Peter A Olson
Director / Other
BUYVested (RSU)136,400
2 tranches
—30
14 Oct 2026
R Jacob Vogelstein
Director / Other
BUYVested (RSU)20,300—30
14 Oct 2026
Evan Lockwood Rachlin
Director / Other
BUYVested (RSU)20,300—30
14 Oct 2026
Thomas F. Miller
Director / Other
BUYVested (RSU)925,400
2 tranches
—30
14 Oct 2026
Neil Josephson
Director / Other
BUYVested (RSU)216,900
2 tranches
—30
14 Oct 2026
Michael Secora
Director / Other
BUYVested (RSU)198,700
2 tranches
—30
14 Oct 2026
Shalini Sharp
Director / Other
BUYVested (RSU)20,300—30
14 Oct 2026
Mary Tagliaferri
Director / Other
BUYVested (RSU)20,300—30
14 Oct 2026
Kurt Von Emster
Director / Other
BUYVested (RSU)20,300—30
14 Oct 2026
William H Rastetter
Director / Other
BUYVested (RSU)40,600—30
Data: Finnhub (SEC Form 4 filings) · Score: ETFpeek heuristic
4 trades
DateFundDirectionShares Changed% Δ ETF i% Δ Position i
23 Oct 2026ARKGBUYAdded+6,601-0.03%0.50%
22 Oct 2026ARKGBUYAdded+18,944-0.02%1.45%
21 Oct 2026ARKGBUYAdded+101,304+0.03%8.25%
20 Oct 2026ARKGBUYNew position+1,254,689+0.98%100.00%
No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal.

More stocks in these funds